We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH PROHIBITS STAFF COLLABORATION WITH DRUG, BIOTECH FIRMS
NIH PROHIBITS STAFF COLLABORATION WITH DRUG, BIOTECH FIRMS
September 24, 2004
In a sudden policy shift, NIH has implemented a one-year moratorium on all staff consulting with pharmaceutical and biotechnology companies — a move that accelerates NIH’s earlier proposal to reduce employee conflicts of interest.